Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,875,027 papers from all fields of science
Search
Sign In
Create Free Account
lenalidomide 25 MG Oral Capsule [Revlimid]
Known as:
Revlimid 25 MG Oral Capsule
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Croscarmellose Sodium
Magnesium stearate
Oral Capsule
Revlimid
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Lenalidomida (▼Revlimid): reactivación viral
A. E. D. M. Y. P. Sanitarios
2017
Corpus ID: 187547864
2016
2016
lenalidomide (REVLIMID°) in untreated multiple myeloma.
Prescrire international
2016
Corpus ID: 73444458
In an unblended trial in 1623 multiple myeloma patients, treatment with lenalidomide + dexamethasone until disease progression…
Expand
Review
2014
Review
2014
Efficacy and safety of first-line therapy with chlorambucil, rituximab and lenalidomide (Revlimid ® ) (CR 2 ) in elderly patients and young frail patients with advanced Chronic Lymphocytic Leukemia…
Principal Investigator
2014
Corpus ID: 74216942
s and presentations Abstracts and presentations at public meetings will represent the trial as a project under HOVON affiliation…
Expand
2013
2013
Produkt Imnovid
Wiener klinisches Magazin
Wiener klinisches Magazin
2013
Corpus ID: 32120356
Imnovid® ist ein neuer Wirkstoff aus der Klasse der IMiDs® (Immunmodulatoren). Mit einer Standarddosierung von 4 mg (orale Gabe…
Expand
Review
2010
Review
2010
Thalidomide and Analogs
E. Gardner
,
G. Lorenzo
,
W. Figg
2010
Corpus ID: 68786302
Thalidomide (Thalomid®), originally marketed as a sedative in Europe in the 1950s but withdrawn after teratogenicity was observed…
Expand
Review
2009
Review
2009
IMiDs induce pleiotropic anti-cancer effects
D. Wolf
2009
Corpus ID: 84873862
SummaryLenalidomide (Revlimid®, also known as CC-5013) and pomalidomide (CC-4047) are IMiDs and chemical derivatives of…
Expand
2008
2008
R2: Preliminary Results of a Phase II Study of Lenalidomide and Rituximab in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (NHL).
2008
Corpus ID: 78403315
Abstract 1679 Poster Board I-705 Background Lenalidomide (Revlimid®) is a potent immunomodulatory agent that has recently…
Expand
2006
2006
Traitement du myélome multiple
V. Coiteux
,
S. Tricot
,
M. Wemeau
,
T. Facon
ONCOLOGIE
2006
Corpus ID: 26013805
Résumé:Nous assistons depuis 20 ans à des progrès continus dans la prise en charge des patients atteints de myélome multiple (MM…
Expand
Review
2005
Review
2005
FDA GRANTS PRIORITY REVIEW FOR REVLIMID ® NDA FOR TREATMENT OF LOW- AND INTERMEDIATE- RISK MDS WITH DELETION 5Q CHROMOSOMAL ABNORMALITY
Robert J. Hugin
,
B. Gill
2005
Corpus ID: 68724295
2005
2005
Preliminary Results of a Phase II Study of CC-5013 (Lenalidomide, Revlimid®) in Patients with Cutaneous T-Cell Lymphoma.
C. Querfeld
,
T. Kuzel
,
J. Guitart
,
S. Rosen
2005
Corpus ID: 78293579
Background: Mycosis fungoides (MF)/Sezary syndrome (SS) represent the most common type of cutaneous T-cell lymphoma (CTCL…
Expand